Gennex Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
10.04
-0.3 (-2.9%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 2.73 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
172.74
148.33
91.62
69.55
62.59
59.65
55.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
172.74
148.33
91.62
69.55
62.59
59.65
55.62
Raw Material Cost
139.62
100.59
57.88
46.91
40.01
34.19
35.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-11.09
-3.51
-9.03
-7.00
-1.91
1.53
-1.51
Employee Cost
8.04
8.35
7.79
7.87
6.97
7.21
6.81
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
13.74
15.76
13.04
13.13
10.76
10.19
11.94
Total Expenditure (Excl Depreciation)
150.30
121.19
69.68
60.91
55.83
53.12
52.37
Operating Profit (PBDIT) excl Other Income
22.44
27.14
21.94
8.64
6.76
6.53
3.25
Other Income
8.25
10.43
0.00
0.00
0.00
0.52
0.95
Operating Profit (PBDIT)
30.69
37.57
21.94
8.64
6.76
7.05
4.20
Interest
4.20
3.61
3.08
1.35
0.88
0.74
0.75
Exceptional Items
-0.60
-0.15
0.00
0.00
0.00
-0.37
0.11
Gross Profit (PBDT)
25.89
33.81
18.86
7.29
5.88
5.94
3.56
Depreciation
2.65
1.99
2.37
0.92
0.79
0.88
1.01
Profit Before Tax
23.24
21.40
16.49
6.37
5.09
5.06
2.55
Tax
2.26
3.27
3.32
1.45
1.17
1.02
0.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.98
18.12
13.18
4.92
3.92
4.04
1.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.98
18.12
13.18
4.92
3.92
4.04
1.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.52
-2.00
-0.85
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.46
16.12
12.32
4.92
3.92
4.04
1.86
Equity Capital
24.29
22.74
22.74
17.66
12.65
12.65
12.65
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
198.23
158.22
141.92
62.33
31.17
27.06
0.00
Earnings per share (EPS)
0.76
0.71
0.54
0.28
0.31
0.32
0.15
Diluted Earnings per share
0.76
0.78
0.61
0.35
0.32
0.32
0.15
Operating Profit Margin (Excl OI)
12.99%
19.68%
25.3%
13.17%
11.04%
10.95%
5.84%
Gross Profit Margin
14.99%
24.52%
21.75%
11.11%
9.61%
9.96%
6.4%
PAT Margin
12.15%
13.14%
15.2%
7.5%
6.4%
6.77%
3.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 16.46% vs 61.90% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 14.52% vs 30.84% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -17.32% vs 23.70% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 16.34% vs 17.21% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Gennex Lab. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
172.74
0
172.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
172.74
0
172.74
Raw Material Cost
139.62
0
139.62
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-11.09
0
-11.09
Employee Cost
8.04
0
8.04
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
13.74
0.00
13.74
Total Expenditure (Excl Depreciation)
150.30
0
150.30
Operating Profit (PBDIT) excl Other Income
22.44
0.00
22.44
Other Income
8.25
0
8.25
Operating Profit (PBDIT)
30.69
0
30.69
Interest
4.20
0
4.20
Exceptional Items
-0.60
0
-0.60
Gross Profit (PBDT)
25.89
0
25.89
Depreciation
2.65
0
2.65
Profit Before Tax
23.24
0
23.24
Tax
2.26
0
2.26
Provisions and contingencies
0.00
0
0.00
Profit After Tax
20.98
0
20.98
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
20.98
0
20.98
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-2.52
0
-2.52
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.46
0
18.46
Equity Capital
24.29
0
24.29
Face Value
1.00
0
0.00
Reserves
198.23
0
198.23
Earnings per share (EPS)
0.76
0
0.76
Diluted Earnings per share
0.76
0
0.76
Operating Profit Margin (Excl OI)
12.99%
0%
0.00
12.99%
Gross Profit Margin
14.99%
0%
0.00
14.99%
PAT Margin
12.15%
0%
0.00
12.15%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 172.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.46% vs 61.90% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 18.46 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 14.52% vs 30.84% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.44 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -17.32% vs 23.70% in Mar 2025

Annual - Interest
Interest 4.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.34% vs 17.21% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.99%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025